Home » House Committee to Question FDA on Future of Avastin MBC Indication
House Committee to Question FDA on Future of Avastin MBC Indication
House Energy and Commerce Committee Chair Fred Upton (R-Mich.) is expected to question senior FDA officials this week about the agency’s upcoming decision on whether to keep Avastin’s metastatic breast cancer (MBC) indication.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May